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Although psychological treatments for depressive disorders are available, they are often expensive or
inaccessible for many. Web-based interventions that require minimal or no contact with therapists
have been shown effective. To the best of our knowledge, no study using this treatment format has
been conducted in Brazil. The Deprexis program was designed using empirically established principles
of cognitive-behavioral therapy to reduce depressive symptoms. The objective of this study was to
evaluate the effectiveness of Deprexis in Brazil. This randomized controlled trial will include 128
Brazilians with clinically significant depression symptoms or who have been diagnosed with depressive
disorder (major depressive disorder or dysthymia), recruited over the internet (Brazilian forums, social
networks, or e-mail lists). Individuals with other psychiatric diagnoses that require significant attention
(e.g., bipolar disorder, psychosis) will not be included in the trial. Participants will be randomly
assigned to 1) treatment as usual plus immediate access to Deprexis or 2) treatment as usual plus
delayed access to Deprexis (after 8 weeks). Participants will be able to obtain other treatment types in
addition to the online intervention. If found effective, this web-based intervention would increase the
evidence-based care options for depression treatment in Brazil.
Clinical trial registration: RBR-6kk3bx, UTN U1111-1212-8998
Keywords: Depression; online interventions; self-guided interventions; cognitive-behavioral
psychotherapy
Introduction
Major depressive disorder (MDD) and dysthymia are chara-
cterized by symptoms such as a sad, empty or irritable
mood, anhedonia and specific somatic and cognitive
changes that reduce quality of life and affect an indivi-
dual’s social and occupational functioning.1 Depression is
one of the leading causes of functional impairment.2-4
Suicide is strongly related to depression; in fact, about
half of those who attempt suicide are depressed, and
as many as 15% of people suffering from depression
will commit suicide.5 The estimated economic burden
of depression includes direct medical costs (31%), costs
related to mortality from suicide (7%), and costs asso-
ciated with occupational impairment (62%).6 Still, depres-
sive disorders are among the most common mental
health problems for which help is sought.7,8 Evidence
suggests that those who most need help (i.e., the people
with more severe depressive symptoms) seek treatment
the least.9
Although some psychological treatments for unipolar
depression have been supported by evidence,10 this
evidence is debatable, in part due to potential publication
bias.11 Furthermore, a considerable number of patients
abandon treatment without substantial improvement or
relapse after treatment.12,13 A large proportion of dep-
ressed people receive no treatment at all.14 General
barriers to psychotherapy include its high costs, extensive
commutes, time constraints, negative evaluations of
psychotherapy, and availability of services.15,16 More-
over, in many parts of the world, there is a shortage of
qualified professionals, especially in areas far from urban
centers,17 while in large centers the most affordable
services have long waiting lists. It is also known that many
clients do not seek help due to the stigma associated with
psychological and psychopharmacological treatment.18
Specific barriers to treatment have been found among
depressed people, such as lack of motivation, emotional
concerns,15 and negative perception of the effectiveness
of psychotherapy.9 Thus, research on different treatment
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formats has been recommended,19-22 and Internet treat-
ments have gained popularity in recent years.23,24
There is a clear distinction between online psychother-
apy and Internet-based self-administered interventions.
Online psychotherapy is usually synchronous, performed
by professionals via virtual interaction platforms (e.g.,
Skype®), and does not exclude the possibility of face-
to-face interaction. Internet-based psychological inter-
ventions are usually asynchronous, conducted through
self-administered programs that target psychoeducation
and involve therapeutic tasks that are structured and
systematic. Little contact with a therapist is presumed,
since their perspective is support and problem solving.
The advantages of online, self-guided interventions include
potentially lower costs, greater geographic reach, privacy,
flexibility (treatment is available anytime and anywhere
Internet access is available), the ability to repeat exer-
cises, and adaptation to the client’s everyday context
rather than the therapist’s office. Research outside Brazil,
mainly in Switzerland, Sweden, the Netherlands, Germany,
Australia, and the United Kingdom, suggests that some
(but not all) internet-based self-guided psychological
interventions are effective.25-30 Evidence from direct
comparisons suggests that Internet-based interventions
with some therapist support are as effective as face-to-
face interventions.31,32 In an individual patient-level
meta-analysis reviewing the efficacy of self-guided
internet-based interventions (without assistance from
therapists) for depression, an average effect size of d = 0.27
was reported,33 which is considered a small effect.34
However, programs may differ in efficacy. For example, a
meta-analysis of a specific Internet intervention for depres-
sion (Deprexis) reported large effect sizes averaging
d = 0.54, based on eight randomized controlled trials
conducted in German-speaking countries and the United
States.35
In Brazil, the Federal Council of Psychology regulates
the Internet-mediated psychological practice with Resolu-
tion 011/2018.36 In this document, Brazilian psychologi-
sts are authorized to provide treatment through online
services such as Skype®, FaceTime®, and text services
(e-mail, chat applications, messaging, etc.). However,
research on such interventions is at an early stage37 and,
to date, very few empirical studies assessing online
treatment effectiveness have been conducted. We know
of no studies in Brazil that have evaluated the effective-
ness of an Internet-based intervention for a psychological
problem in a controlled manner. Thus, more studies on
the results and processes of Internet-based psychother-
apy are necessary to better evaluate the impact of this
type of treatment with potential users in Brazilian.37
Deprexis (https://deprexis.broca.io/en/) is an estab-
lished online intervention for depression that has already
been tested in 12 randomized controlled trials.35,38-41.
Deprexis uses an integrative approach, based primarily
on cognitive behavioral therapy.42 Evidence for the effec-
tiveness of this program has been reported in Europe,
especially German-speaking countries29,42-47, as well as in
the United States.48 However, these results were obtained
in high-income countries. This program has been trans-
lated into eight languages, including Brazilian Portuguese,
and some efforts have already been made for cultural
adaptation to Brazil, although no study has been conducted
with groups of Brazilians suffering from depression.
The main objective of this study is to replicate empirical
effectiveness studies conducted in other countries, using
Deprexis in the Brazilian cultural context. Therefore, the
main research question is: will the therapeutic results
(i.e., reduction of depressive symptoms) in Brazil be similar
those obtained in other countries (i.e., medium to large
effect sizes, compared to treatment as usual [TAU])?
Methods
This study will be a randomized controlled trial with a
parallel-group design. The selected participants will be
allocated randomly into two groups: 1) immediate access
to Deprexis; and 2) a wait-list control group that receives
delayed access to Deprexis. Both groups will be allowed
access to any other treatments that they or their care
providers deem necessary, i.e., TAU (psychotherapy,
psychopharmacology, or both). Deprexis will be used
alone or together with TAU.
Participants
Participants must have the following characteristics for
inclusion in the study: 1) be at least 18 years of age;
2) have regular Internet access; 3) be diagnosed with a
depressive disorder (MDD or dysthymia) according to
DSM-5 definitions1; or 4) present clinically relevant
depressive symptoms, i.e. a score of at least 10 on the
Patient Health Questionnaire-9 (PHQ-9).49,50 Participants
may be undergoing any other psychopharmacological
or psychotherapeutic treatment (TAU) to manage their
depressive symptoms. Participants will be excluded from
the study if they: 1) present other severe psychiatric
symptoms that are the primary focus of specific clinical
attention (e.g., severe psychotic symptoms, manic epi-
sodes); 2) show the potential to injure themselves or
others; 3) present severe suicidal ideation; 4) are
psychiatric patients adapting to medication (having been
on medication for less than a month, or having changed
their dosage in the past month, or intending to switch
medications within 3 months after the trial starts); 5) do
not have regular Internet access; or 6) are using illegal
drugs or have high alcohol intake (more than three
drinks per day). Candidates ineligible for the study will be
contacted (by telephone, e-mail, or during the interview)
for feedback on the initial evaluation and will be referred
to face-to-face public mental health services in their
area. Using simple randomization procedures (computer-
ized random numbers), the selected participants will
be randomly assigned to either TAU plus immediate
access to Deprexis, or TAU plus delayed access to
Deprexis (after 8 weeks). The randomization scheme
will be generated with a random algorithm developed
at http://www.randomization.com. To ensure allocation
concealment, the research team members performing
the randomization will not be aware of any participant
characteristics. The research team member who randomly
allocates participants in both groups will be different from
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the one who applies inclusion/exclusion criteria, and
these research team members will not have contact with
each other.
Recruitment
A website (https://sites.google.com/view/ficabem/), a
Facebook page (@p.ficabem) and an Instagram profile
(@p.ficabem) have been set up to provide necessary
information about the research procedures and online
intervention, as well as to recruit participants. The link will
be advertised on the main social networks and e-mail lists
of associations of mental health professionals in Brazil.
We also intend to announce the research opportunity in
traditional media and mental health services.
Eligibility assessment
Potential participants will be asked to complete a consent
form, the sociodemographic questionnaire, the PHQ-9,
and the Clinical Outcome in Routine Evaluation – Out-
come Measurement (CORE-OM) when logging on to the
study platform for the first time. In order to assess the
exclusion and inclusion criteria and confirm the severity of
depressive symptoms, an interview based on the Adult
DSM-5 Cross-Cutting Symptom Measure1 will be held
by phone or on online platforms such as Skype® or
WhatsApp®.
Instruments
Sociodemographic questionnaire
The assessed demographic variables will be age, gender,
location in Brazil, and Internet access.
Adult DSM-5 Cross-Cutting Symptom Measure
For the initial screening, a semi-structured diagnostic
interview based on DSM-5 diagnostic criteria will be
applied. The interview assesses mental health domains
that are important across psychiatric diagnoses. The adult
version of the measure consists of 23 questions that
evaluate 13 psychiatric domains, including depression,
suicidal ideation, mania, anxiety, anger, somatic symp-
toms, psychosis, sleep problems, memory, repetitive
thoughts and behaviors, dissociation, personality func-
tioning, and substance use. The original English version
of the measure had good to excellent test-retest reliability
in DSM-5 field trials conducted in adult clinical samples
across the United States and Canada.51,52 We included
questions about any previous diagnosis and former and
current treatments.
Patient Health Questionnaire49,50
Consisting of nine questions, the PHQ-9 assesses the
presence of each of the symptoms for a major depressive
episode described in the DSM-5.1 The nine symptoms
include depressed mood, anhedonia (loss of interest in or
inability to experience pleasure from normally pleasant
stimuli), sleeping problems, tiredness or lack of energy,
change in appetite or weight, feelings of guilt or useless-
ness, concentration problems, feelings of lethargy or
restlessness, and suicidal thoughts. Brazilian psychia-
trists translated the PHQ-9 into Portuguese and a back
translation was performed by one of the authors of the
original instrument.53 The frequency of each symptom
in the previous 2 weeks is assessed on a Likert scale
from 0 to 3 corresponding to ‘‘never,’’ ‘‘several days,’’
‘‘more than half of the days,’’ and ‘‘almost every day,’’ res-
pectively. The questionnaire also includes a 10th question
to assess the interference of these symptoms in daily
activities, such as work and study. The cutoff score
will be 10 points, as is widely used among Brazilian
researchers.49,54-56
Clinical Outcome in Routine Evaluation – Outcome
Measurement57,58
The CORE-OM is a widely used self-report scale for
evaluating the effectiveness of mental health treatments.
It includes 34 items assessing the following four domains:
subjective well-being (four items), problems and symp-
toms (12 items), life functioning (12 items), and risk to self
and others (six items). These items are answered on a
five-point scale, ranging from ‘‘never’’ to ‘‘always.’’ A UK
study with a clinical (n=890) and a non-clinical sample
(n=1,106) found an overall internal consistency index
(Cronbach’s alpha) of 0.94 for both samples. Test-retest
correlations with part of the sample (n=55) ranged from
0.87 to 0.91 for well-being, problems and symptoms, and
life functioning domains, although the risk to self and others
domain scored 0.64, showing low temporal stability.
Convergent validity was verified by correlating total
scores and domain scores with overall scores from other
psychological symptom scales, resulting in correlations
ranging from 0.55 to 0.88.7.57
Client Satisfaction Questionnaire (CSQ-8)59
The CSQ-8 is a self-report questionnaire designed to
assess the general level of satisfaction with provided
services. Its eight items are scored on a scale from 1 to 4.
Total scores vary from 8 to 32 points, with higher scores
indicating greater satisfaction with the service. The inter-
nal consistency of the original English version scale ranges
from 0.83 to 0.93.60
Usage duration
We will measure the number of sessions lasting at least
10 minutes spent in the program, as well as the number of
days with such usage. The system generates these
indicators based on each client’s use as an objective
measure of treatment adherence.
Procedures
The informed consent and self-report measures will be
obtained online by participants at the initial screen-
ing questionnaire, prior to inclusion and randomization.
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Participants will confirm that they read and consented to
the terms of the study. They may also discontinue parti-
cipation, as well as contact the staff for further informa-
tion. After completing the baseline assessment and being
included in the study, participants randomized to the
intervention group will promptly receive a voucher to
access the program for 90 days. The time point of primary
interest will be 8 weeks after the baseline assessment.
Participants randomized to the delayed access group will
receive a voucher 8 weeks after randomization and will be
asked to fill out the primary (PHQ-9) and secondary
(CORE-OM) outcome measures once more. After com-
pleting the program, all participants will be invited to fill out
the outcome measures and answer a final questionnaire
that includes items on whether the program was used
alone or together with psychotherapy or psychopharma-
cology. The participants will also be asked about signifi-
cant life events that occurred during the course of the
intervention.
The research team includes senior undergraduate
psychology students, who will be in charge of the
screening interviews. These students will be trained and
supervised by three clinical psychologists on the research
team. The interviews will be assigned by convenience and
according to availability. The research team will also be
responsible for: 1) recruitment advertising; 2) analyzing
the screening questionnaires and excluding participants
who do not follow the criteria; 3) randomizing participants
and following up questionnaire responses; 4) e-mail
communication with participants throughout the study;
5) checking and providing feedback about program usage;
and 6) sending out post-treatment assessment forms; 7) in
accordance with procedures used in a previous study on
Deprexis (Beevers et al.48), the research team will send
messages to participants every 2 weeks to encourage
them to use Deprexis, to assess potential problems or
difficulties, and to monitor potentially adverse events
they might experience during the intervention.
Treatment
Deprexis is an internet-based intervention program to
help people learn about and cope with depressive
symptoms.42 It is based on the principles of cognitive-
behavioral therapy and consists of 10 original content
modules plus one short review module, including psy-
choeducation, behavioral activation, cognitive restructuring,
mindfulness and acceptance, social and communication
skills, relaxation exercises, suggestions for physical activity
and healthy dieting, problem solving methods, expressive
writing, and forgiveness, as well as working with dreams
from a cognitive-behavioral perspective.42,61 Content is
presented in simulated dialogue format, in which users
continuously choose one of several predetermined response
options, and subsequent content is automatically adapted
to user needs and characteristics.
Deprexis sends daily messages with therapeutic con-
tent to help in everyday life (e.g., becoming aware of
unhelpful automatic thoughts, organizing the day, break-
ing down significant problems into small steps, and
interacting with people). Deprexis is designed for both
mobile and desktop devices. The program can be used
without any therapist contact, although in our clinical trial
trained clinical psychologists and psychology students will
keep minimal regular contact with users by e-mail (i.e.,
minimally supported or guided use). Deprexis has been
carefully translated and adapted to Brazilian Portuguese
and culture by expert Portuguese language professionals.
In addition, Brazilian psychology students and psycholo-
gists used the program and suggested language and
cultural adjustments
Sample size and statistical analyses
The sample size of this study is based on the expected
difference in the primary outcome variable (PHQ-9 score,
which measures the severity of depressive symptoms)
between the group receiving the intervention and the
control group after 3 months. Based on a statistical
strength estimate of at least 0.80 in a two-tailed test and
an alpha of 0.05, a sample of 128 participants (64 per
group) will be sufficient to demonstrate a likely effect size
of d = 0.50 (moderate effect). Following the intention-to-
treat principle, data from all 128 randomized participants
will be analyzed. We anticipate a treatment withdrawal
rate of around 20% at the first measurement point (after
3 months). This rate has been achieved in several
prior clinical trials with Deprexis.48 Based on previous
research,29,35,42,47,48 predicting a moderate effect size
seems realistic. This calculation is based on the assump-
tion that a 50:50 randomization procedure will be used.
Both the intention-to-treat and the per protocol ana-
lyses will be conducted using appropriate statistical
methods, such as linear mixed models, which are widely
used in this field of research and have been recom-
mended due to their ability to properly treat lost data.
Additional analyses will be performed to examine the
potential influence of intervening variables on the primary
outcome measure (e.g., initial differences in symptom
severity or intensity of Deprexis use). The PHQ-9 will be
the primary clinical outcome measure, and the CORE-OM
will be the secondary outcome measure. The results will
be reported according to CONSORT guidelines.62,63
The clinical significance of the changes observed at
the end of the intervention in both experimental conditions
will be evaluated using the Jacobson & Truax64 method.
This analysis method takes into account the scores of
the general and clinical populations to obtain a clinical
threshold for a given psychological measure. Chi-square
tests will be used to compare the rates of clinical impro-
vement and recovery, as well as any clinically significant
deterioration ratios between groups.
Ethics statement
This research protocol has been approved by the research
ethics committee of the Universidade Cato´lica de Petro´po-
lis (CAAE # 68709517.1.0000.5281) and has been regi-
stered in the Brazilian Clinical Trials Registry (Registro
Brasileiro de Ensaios Clı´nicos [ReBEC]; RBR-6kk3bx,
UTN U1111-1212-8998; http://www.ensaiosclinicos.gov.
br/rg/RBR-6kk3bx/). Similar experimental protocols using
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Deprexis have already been approved by the research
ethics committees of several European and U.S. univer-
sities, as well as the Data Security Department of
Hamburg, Germany. The ethics code for practicing
psychology in Brazil65 and previously mentioned Federal
Council of Psychology guidelines for internet interven-
tions (Resolution 011/2018)36 are also being taken into
account.
All selected clients who decide to participate in the
study will be required to complete an informed consent
form approved by the local research ethics committee.
The participants’ e-mail addresses will be collected for
logging in to Deprexis, retrieving lost passwords, and
receiving daily messages. No participant names, addres-
ses, or internet protocol addresses will be stored after the
trial is completed. Stored data security will be ensured
through the secure sockets layer protocol, which provides
internet communication security for services such as
e-mail, page navigation, and other types of data transfer.
The intervention data will be stored on a secure server
in Germany and will be protected by a modern, reliable
firewall, and a current transport layer security configura-
tion to encrypt all data in transit. Users will provide their
e-mail addresses and a personal password, which is
encrypted by the system. Thus, passwords, even if stolen,
cannot be used. All employees of GAIA Group’s informa-
tion technology department are trained in data privacy
and are governed by German law.
Discussion
This study was designed in an effort to meet a perceived
need for research on different depression intervention
formats, especially in low- to middle-income countries,
such as Brazil. The effectiveness of internet-based
interventions suggests that this could be a viable alter-
native in depression treatment due to its flexibility, lower
costs, and adaptability to the patient’s daily routine and
location. As far as we know, no web-based interventions
for depression have been developed in Brazil. We are
aware of the considerable amount of human resources
necessary to develop such an intervention. Deprexis has
been developed for many years now and has undergone
numerous improvements. It has been carefully transla-
ted and adapted to the Brazilian Portuguese language
and culture. It is expected that this study will replicate
and extend the evidence found in previous studies on
Deprexis.
We are currently recruiting the first participants. We
have chosen to recruit participants over the Internet,
assuming that this is the primary medium through which
they would hear about the program under similar condi-
tions. Although online recruitment introduces a selection
bias toward individuals suffering from depressive symp-
toms who actively seek help online, such individuals
can also be considered the intended target group for
Deprexis. Deprexis can also be recommended to patients
by their psychiatrists or psychologists, but they will not
be the main focus of our recruitment strategy, which could
be regarded as a possible study limitation.
Another possible study limitation concerns the exclu-
sion of candidates with severe comorbidities. Although we
will accept candidates with comorbid anxiety and other
mild problems, for safety reasons, we will not include
patients with severe symptoms that may require special
attention, such as panic disorder, schizophrenia, alcohol
abuse, etc. Excluding this population could result in a
relatively heterogeneous group of patients, which is
probably not representative of the population of Deprexis
users.
Another conceivable limitation is participants who un-
dergo psychotherapy or psychopharmacology during the
online intervention process. In a group of 128 partici-
pants, it is expected that some will voluntarily seek different
sources of treatment during the intervention, which can be
considered a study limitation. On the other hand, setbacks
such as significant losses and illness can happen randomly
to all participants, both those who seek external help and
those who do not, which can thus be considered a strength
of the study design. Allowing participants access to TAU
(psychiatry and clinical psychology services) could improve
the external validity of our results. We can assume that an
individual who is suffering from depression will seek help
from different sources, either professional treatment or
online information. Both scenarios will be considered and
assessed in the final questionnaire.
Having a randomized control group with delayed access
to Deprexis is among the study’s strengths. We are aware
that the depressive symptoms of participants randomized
to delayed intervention may decrease naturally with the
passage of time, other professional or lay intervention,
or significant life changes. Nevertheless, we assume
that the potential symptom reduction in this group will make
a reliable comparison to the group that gains immediate
access to Deprexis.
In Brazil, research on easily accessible Internet-based
intervention programs is at an early stage. Rigorous
clinical trials on the effectiveness of such programs in
Brazil are needed. To the best of our knowledge, this will
be the first controlled trial to evaluate the effectiveness of
an Internet-based program for depression in Brazil.
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